Bri-Chem Corp. continues to face challenges in the market amid recent financial disclosures and stock performance.
Bri-Chem Corp. (BRY.TO) saw its stock decline by 2.70% on Tuesday, closing at C$0.36. This marked a continuation of the downward trend for the week, with shares also down by 2.70% over the past week. However, the stock has shown some resilience over the past month with a gain of 10.77%, and a remarkable year-to-date increase of 63.64%.
Advertisement
Bri-Chem Corp.
BRY.TO
BRY.TO
Bri-Chem Corp.
WealthAwesomeAdvertisement
Market cap
$9.52M
P/E
5.1x
52W high
$0.44
52W low
$0.20
1W change
-2.70%
Beta
-0.75
Analyst Price Targets
Based on analyst covering BRY
Wall Street analysts forecast BRY stock price to fall 38.9% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.22
-38.9% Upside
Current Price
C$0.36
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRY's historical volatility
30-Day Vol
64.7%
Annualized
90-Day Vol
76.0%
Annualized
Trend (90d)
-11.5%
Annualized drift
90d Mean
C$0.35
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.36 | C$0.28 – C$0.44 |
| 60 trading days | C$0.35 | C$0.26 – C$0.48 |
| 90 trading days | C$0.35 | C$0.23 – C$0.51 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor Bri-Chem's financial performance and any developments related to its supply agreements and market strategies, as these factors could significantly impact future stock performance.
Bri-Chem's stock down 2.70% on Tuesday, closing at C$0.36.
Despite recent declines, Bri-Chem has seen a notable year-to-date increase of 63.64%, reflecting some resilience in its stock performance.
Bull case
The recent supply agreement with Reliant Technologies could improve Bri-Chem's product offerings, which may lead to better sales and profitability down the line.
Bear case
Recent financial results show declining sales and negative EBITDA, which could continue to affect investor sentiment and stock performance.
Recent Price Action
Bri-Chem Corp. (BRY.TO) closed at C$0.36 on Tuesday, reflecting a 2.70% decrease for the day. This downward trajectory is mirrored in the weekly performance, also down by 2.70%. Over the past month, however, the stock has managed to gain 10.77%. Year-to-date, Bri-Chem's shares have appreciated significantly, rising 63.64%.
Company News and Developments
Advertisement
No major company news was reported this week. However, Bri-Chem recently announced a formal supply agreement with Reliant Technologies, effective February 17, 2026. This agreement aims to strengthen Bri-Chem's product portfolio with advanced technologies and specialty chemical formulations. Notably, the CEO of Bri-Chem, Barry Hugghins, has a substantial ownership stake in Reliant, making this a related-party transaction.
Technical Picture
The technical indicators for Bri-Chem show that the stock is trading at its 50-day moving average of C$0.36, which is slightly below the current price by 0.4%. The 200-day moving average stands at C$0.29, indicating a positive divergence of 22.2%. The stock has a 52-week range of C$0.20 to C$0.44, currently trading at 67% of this range. With a beta of -0.75, the stock exhibits less volatility compared to the market.
Insider Activity
No insider activity has been reported this week.
Price Action Summary
Bri-Chem Corp. closed at C$0.36, down 2.70% on the day.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
